Karmanos Cancer Institute Dept of Oncology — Detroit, Michigan

Karmanos Cancer Institute Dept of Oncology is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Dept of Oncology has participated in 2 clinical trials.

Therapeutic areas: Locally Advanced or Metastatic NRAS Mutant Melanoma, Locally Advanced Metastatic BRAF Mutant Melanoma.

Sponsors: Pfizer, Array BioPharma.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Dept of Oncology?

Karmanos Cancer Institute Dept of Oncology has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Dept of Oncology conducted?

Karmanos Cancer Institute Dept of Oncology has 2 clinical trials on record. Their work covers Locally Advanced or Metastatic NRAS Mutant Melanoma, Locally Advanced Metastatic BRAF Mutant Melanoma.

Is Karmanos Cancer Institute Dept of Oncology accredited by Crixeo Health?

Karmanos Cancer Institute Dept of Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Dept of Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.